Telomir Pharmaceuticals
TELO
#10427
Rank
$42.14 M
Marketcap
$0.57
Share price
-17.09%
Change (1 day)
-58.24%
Change (1 year)

Quarterly Reports (10-Q)

Latest form 10-Q quarterly reports for Telomir Pharmaceuticals CIK: 0001971532

Thumbnail Telomir Pharmaceuticals 10-Q Quarterly Report FY2026 Q3

10-Q Quarterly Report FY2026 Q3

Language: English

Quarterly Reports (10-Q)
Thumbnail Telomir Pharmaceuticals 10-Q Quarterly Report FY2026 Q2

10-Q Quarterly Report FY2026 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail Telomir Pharmaceuticals 10-Q Quarterly Report FY2026 Q1

10-Q Quarterly Report FY2026 Q1

Language: English

Quarterly Reports (10-Q)
Thumbnail Telomir Pharmaceuticals 10-Q Quarterly Report FY2025 Q3

10-Q Quarterly Report FY2025 Q3

Language: English

Quarterly Reports (10-Q)
Thumbnail Telomir Pharmaceuticals 10-Q Quarterly Report FY2025 Q2

10-Q Quarterly Report FY2025 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail Telomir Pharmaceuticals 10-Q Quarterly Report FY2025 Q1

10-Q Quarterly Report FY2025 Q1

Language: English

Quarterly Reports (10-Q)
Thumbnail Telomir Pharmaceuticals 10-Q Quarterly Report FY2024 Q3

10-Q Quarterly Report FY2024 Q3

Language: English

Quarterly Reports (10-Q)
Thumbnail Telomir Pharmaceuticals 10-Q Quarterly Report FY2024 Q2

10-Q Quarterly Report FY2024 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail Telomir Pharmaceuticals 10-Q Quarterly Report FY2024 Q1

10-Q Quarterly Report FY2024 Q1

Language: English

Quarterly Reports (10-Q)